Stifel Financial’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,101
Closed -$19K 3506
2022
Q1
$19K Buy
2,101
+1,434
+215% +$21.8K ﹤0.01% 3344
2021
Q4
$14K Hold
667
﹤0.01% 3352
2021
Q3
$22K Sell
667
-10,500
-94% -$385K ﹤0.01% 3305
2021
Q2
$466K Buy
11,167
+4,819
+76% +$247K ﹤0.01% 2623
2021
Q1
$415K Buy
6,348
+4,128
+186% +$288K ﹤0.01% 2593
2020
Q4
$146K Buy
+2,220
New +$145K ﹤0.01% 2890

Other funds holding SRGA

Stifel Financial's SRGA Position: Q2 2022 in Review

Stifel Financial sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2022, closing a stake of 2,101 shares — an estimated $19K sold.

Stifel Financial first reported a position in SRGA in Q4 2020 and held it in 6 quarters. The position peaked at $466K in Q2 2021. 40 funds tracked by Wall St. Rank hold SRGA as of Q2 2022.

  • Stifel Financial reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Stifel Financial sold 2,101 Surgalign Holdings, Inc. Common Stock shares in Q2 2022, an estimated $19K.
  • Stifel Financial first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Stifel Financial's Surgalign Holdings, Inc. Common Stock position peaked at $466K in Q2 2021.
  • 40 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2022.

Based on Stifel Financial's 13F filing for Q2 2022, filed 15 Aug 2022.